AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab (December 13, 2005). doi:10.1152/ajpendo.00397.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/E798    most recent
00397.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Mao, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Mao, Q.
Submitted on August 29, 2005
Accepted on December 7, 2005

Regulation of BCRP/ABCG2 Expression By Progesterone And 17{beta}-Estradiol in Human Placental BeWo Cells

Honggang Wang1, Lin Zhou1, Anshul Gupta1, R. Robert Vethanayagam1, Yi Zhang1, Jashvant D Unadkat1, and Qingcheng Mao1*

1 Department of Pharmaceutics, University of Washington, Seattle, WA, USA

* To whom correspondence should be addressed. E-mail: qmao{at}u.washington.edu.

The breast cancer resistance protein (BCRP) is abundant in the placenta and protects the fetus by limiting placental drug penetration. We hypothesize that pregnancy-specific hormones regulate BCRP expression. Hence, we examined the effects of progesterone (P4) and 17{beta}-estradiol (E2) on BCRP expression in the human placental BeWo cells. P4 and E2 significantly increased and decreased BCRP protein and mRNA, respectively. Likewise, treatment with P4 and E2 respectively increased and decreased fumitremorgin C-inhibitable mitoxantrone efflux activity of BeWo cells. Reduction in BCRP expression by E2 was abrogated by the estrogen receptor (ER) antagonist ICI 182,780. However, the progesterone receptor (PR) antagonist RU 486 had no effect on P4-mediated induction of BCRP. P4 together with E2 further increased BCRP protein and mRNA, compared with P4 treatment alone. This combined effect on BCRP expression was abolished by RU 486 or ICI 182,780 or both. Further analysis revealed that E2 significantly decreased ER{beta} mRNA, and strongly induced PRB mRNA in a dose-dependent manner, but had no effect on PRA and ER{alpha}. P4 alone had no significant effect on mRNA of ER{alpha}, ER{beta}, PRA and PRB. E2 in combination with P4 increased PRB mRNA, but the level of induction was significantly reduced compared with E2 treatment alone. Taken together, these results indicate that E2 by itself likely down-regulates BCRP expression through an ER, possibly ER{beta}. P4 alone up-regulates BCRP expression via a mechanism other than PR. P4 in combination with E2 further increases BCRP expression, presumably via a non-classical PR and/or E2-mediated synthesis of PRB.




This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
X.-D. Fu, M. Flamini, A. M. Sanchez, L. Goglia, M. S. Giretti, A. R. Genazzani, and T. Simoncini
Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin
Mol. Hum. Reprod., April 1, 2008; 14(4): 225 - 234.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Wang, E.-W. Lee, L. Zhou, P. C. K. Leung, D. D. Ross, J. D. Unadkat, and Q. Mao
Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells
Mol. Pharmacol., March 1, 2008; 73(3): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Yokoo, A. Hamada, H. Watanabe, T. Matsuzaki, T. Imai, H. Fujimoto, K. Masa, T. Imai, and H. Saito
Involvement of Up-Regulation of Hepatic Breast Cancer Resistance Protein in Decreased Plasma Concentration of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Coadministration of S-1 in Rats
Drug Metab. Dispos., September 1, 2007; 35(9): 1511 - 1517.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Zhou, M. Hong, and G. You
Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E57 - E61.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. A. Evseenko, J. W. Paxton, and J. A. Keelan
Independent Regulation of Apical and Basolateral Drug Transporter Expression and Function in Placental Trophoblasts by Cytokines, Steroids, and Growth Factors
Drug Metab. Dispos., April 1, 2007; 35(4): 595 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. Grube, S. Reuther, H. Meyer zu Schwabedissen, K. Kock, K. Draber, C. A. Ritter, C. Fusch, G. Jedlitschky, and H. K. Kroemer
Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta
Drug Metab. Dispos., January 1, 2007; 35(1): 30 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Wang, X. Wu, K. Hudkins, A. Mikheev, H. Zhang, A. Gupta, J. D. Unadkat, and Q. Mao
Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors.
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1295 - E1304.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.